Global Golimumab(Simponi) Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
A tumor necrosis factor (TNF)-? inhibitor
The global market for Golimumab(Simponi) is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Golimumab(Simponi) market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Golimumab(Simponi) market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Golimumab(Simponi) market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Golimumab(Simponi) market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Golimumab(Simponi) players cover Chemieliva Pharma, JNJ and DSK Biopharma. etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Golimumab(Simponi) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Golimumab(Simponi) market, with both quantitative and qualitative data, to help readers understand how the Golimumab(Simponi) market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Box.
Market Segmentation:
The study segments the Golimumab(Simponi) market and forecasts the market size by Specification (100Mg/Ml, 50Mg/Ml and 10Mg/Ml), by Application (Hospital, Clinic and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by specification
Chapter 1: Scope of Golimumab(Simponi), Research Methodology, etc.
Chapter 2: Executive Summary, global Golimumab(Simponi) market size (sales and revenue) and CAGR, Golimumab(Simponi) market size by region, by specification, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Golimumab(Simponi) sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Golimumab(Simponi) sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by specification, and specification.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Golimumab(Simponi) market size forecast by region, by country, by specification, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Chemieliva Pharma, JNJ and DSK Biopharma, etc.
Chapter 14: Research Findings and Conclusion
A tumor necrosis factor (TNF)-? inhibitor
The global market for Golimumab(Simponi) is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Golimumab(Simponi) market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Golimumab(Simponi) market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Golimumab(Simponi) market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Golimumab(Simponi) market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Golimumab(Simponi) players cover Chemieliva Pharma, JNJ and DSK Biopharma. etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Golimumab(Simponi) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Golimumab(Simponi) market, with both quantitative and qualitative data, to help readers understand how the Golimumab(Simponi) market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Box.
Market Segmentation:
The study segments the Golimumab(Simponi) market and forecasts the market size by Specification (100Mg/Ml, 50Mg/Ml and 10Mg/Ml), by Application (Hospital, Clinic and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by specification
- 100Mg/Ml
- 50Mg/Ml
- 10Mg/Ml
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Chemieliva Pharma
- JNJ
- DSK Biopharma
Chapter 1: Scope of Golimumab(Simponi), Research Methodology, etc.
Chapter 2: Executive Summary, global Golimumab(Simponi) market size (sales and revenue) and CAGR, Golimumab(Simponi) market size by region, by specification, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Golimumab(Simponi) sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Golimumab(Simponi) sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by specification, and specification.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Golimumab(Simponi) market size forecast by region, by country, by specification, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Chemieliva Pharma, JNJ and DSK Biopharma, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Golimumab(Simponi) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Golimumab(Simponi) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Golimumab(Simponi) by Country/Region, 2017, 2022 & 2028
2.2 Golimumab(Simponi) Segment by Specification
2.2.1 100Mg/Ml
2.2.2 50Mg/Ml
2.2.3 10Mg/Ml
2.3 Golimumab(Simponi) Sales by Specification
2.3.1 Global Golimumab(Simponi) Sales Market Share by Specification (2017-2022)
2.3.2 Global Golimumab(Simponi) Revenue and Market Share by Specification (2017-2022)
2.3.3 Global Golimumab(Simponi) Sale Price by Specification (2017-2022)
2.4 Golimumab(Simponi) Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Golimumab(Simponi) Sales by Application
2.5.1 Global Golimumab(Simponi) Sale Market Share by Application (2017-2022)
2.5.2 Global Golimumab(Simponi) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Golimumab(Simponi) Sale Price by Application (2017-2022)
3 GLOBAL GOLIMUMAB(SIMPONI) BY COMPANY
3.1 Global Golimumab(Simponi) Breakdown Data by Company
3.1.1 Global Golimumab(Simponi) Annual Sales by Company (2020-2022)
3.1.2 Global Golimumab(Simponi) Sales Market Share by Company (2020-2022)
3.2 Global Golimumab(Simponi) Annual Revenue by Company (2020-2022)
3.2.1 Global Golimumab(Simponi) Revenue by Company (2020-2022)
3.2.2 Global Golimumab(Simponi) Revenue Market Share by Company (2020-2022)
3.3 Global Golimumab(Simponi) Sale Price by Company
3.4 Key Manufacturers Golimumab(Simponi) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Golimumab(Simponi) Product Location Distribution
3.4.2 Players Golimumab(Simponi) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GOLIMUMAB(SIMPONI) BY GEOGRAPHIC REGION
4.1 World Historic Golimumab(Simponi) Market Size by Geographic Region (2017-2022)
4.1.1 Global Golimumab(Simponi) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Golimumab(Simponi) Annual Revenue by Geographic Region
4.2 World Historic Golimumab(Simponi) Market Size by Country/Region (2017-2022)
4.2.1 Global Golimumab(Simponi) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Golimumab(Simponi) Annual Revenue by Country/Region
4.3 Americas Golimumab(Simponi) Sales Growth
4.4 APAC Golimumab(Simponi) Sales Growth
4.5 Europe Golimumab(Simponi) Sales Growth
4.6 Middle East & Africa Golimumab(Simponi) Sales Growth
5 AMERICAS
5.1 Americas Golimumab(Simponi) Sales by Country
5.1.1 Americas Golimumab(Simponi) Sales by Country (2017-2022)
5.1.2 Americas Golimumab(Simponi) Revenue by Country (2017-2022)
5.2 Americas Golimumab(Simponi) Sales by Specification
5.3 Americas Golimumab(Simponi) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Golimumab(Simponi) Sales by Region
6.1.1 APAC Golimumab(Simponi) Sales by Region (2017-2022)
6.1.2 APAC Golimumab(Simponi) Revenue by Region (2017-2022)
6.2 APAC Golimumab(Simponi) Sales by Specification
6.3 APAC Golimumab(Simponi) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Golimumab(Simponi) by Country
7.1.1 Europe Golimumab(Simponi) Sales by Country (2017-2022)
7.1.2 Europe Golimumab(Simponi) Revenue by Country (2017-2022)
7.2 Europe Golimumab(Simponi) Sales by Specification
7.3 Europe Golimumab(Simponi) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Golimumab(Simponi) by Country
8.1.1 Middle East & Africa Golimumab(Simponi) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Golimumab(Simponi) Revenue by Country (2017-2022)
8.2 Middle East & Africa Golimumab(Simponi) Sales by Specification
8.3 Middle East & Africa Golimumab(Simponi) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Golimumab(Simponi)
10.3 Manufacturing Process Analysis of Golimumab(Simponi)
10.4 Industry Chain Structure of Golimumab(Simponi)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Golimumab(Simponi) Distributors
11.3 Golimumab(Simponi) Customer
12 WORLD FORECAST REVIEW FOR GOLIMUMAB(SIMPONI) BY GEOGRAPHIC REGION
12.1 Global Golimumab(Simponi) Market Size Forecast by Region
12.1.1 Global Golimumab(Simponi) Forecast by Region (2023-2028)
12.1.2 Global Golimumab(Simponi) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Golimumab(Simponi) Forecast by Specification
12.7 Global Golimumab(Simponi) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Chemieliva Pharma
13.1.1 Chemieliva Pharma Company Information
13.1.2 Chemieliva Pharma Golimumab(Simponi) Product Offered
13.1.3 Chemieliva Pharma Golimumab(Simponi) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Chemieliva Pharma Main Business Overview
13.1.5 Chemieliva Pharma Latest Developments
13.2 JNJ
13.2.1 JNJ Company Information
13.2.2 JNJ Golimumab(Simponi) Product Offered
13.2.3 JNJ Golimumab(Simponi) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 JNJ Main Business Overview
13.2.5 JNJ Latest Developments
13.3 DSK Biopharma
13.3.1 DSK Biopharma Company Information
13.3.2 DSK Biopharma Golimumab(Simponi) Product Offered
13.3.3 DSK Biopharma Golimumab(Simponi) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 DSK Biopharma Main Business Overview
13.3.5 DSK Biopharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Golimumab(Simponi) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Golimumab(Simponi) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Golimumab(Simponi) by Country/Region, 2017, 2022 & 2028
2.2 Golimumab(Simponi) Segment by Specification
2.2.1 100Mg/Ml
2.2.2 50Mg/Ml
2.2.3 10Mg/Ml
2.3 Golimumab(Simponi) Sales by Specification
2.3.1 Global Golimumab(Simponi) Sales Market Share by Specification (2017-2022)
2.3.2 Global Golimumab(Simponi) Revenue and Market Share by Specification (2017-2022)
2.3.3 Global Golimumab(Simponi) Sale Price by Specification (2017-2022)
2.4 Golimumab(Simponi) Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Golimumab(Simponi) Sales by Application
2.5.1 Global Golimumab(Simponi) Sale Market Share by Application (2017-2022)
2.5.2 Global Golimumab(Simponi) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Golimumab(Simponi) Sale Price by Application (2017-2022)
3 GLOBAL GOLIMUMAB(SIMPONI) BY COMPANY
3.1 Global Golimumab(Simponi) Breakdown Data by Company
3.1.1 Global Golimumab(Simponi) Annual Sales by Company (2020-2022)
3.1.2 Global Golimumab(Simponi) Sales Market Share by Company (2020-2022)
3.2 Global Golimumab(Simponi) Annual Revenue by Company (2020-2022)
3.2.1 Global Golimumab(Simponi) Revenue by Company (2020-2022)
3.2.2 Global Golimumab(Simponi) Revenue Market Share by Company (2020-2022)
3.3 Global Golimumab(Simponi) Sale Price by Company
3.4 Key Manufacturers Golimumab(Simponi) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Golimumab(Simponi) Product Location Distribution
3.4.2 Players Golimumab(Simponi) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GOLIMUMAB(SIMPONI) BY GEOGRAPHIC REGION
4.1 World Historic Golimumab(Simponi) Market Size by Geographic Region (2017-2022)
4.1.1 Global Golimumab(Simponi) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Golimumab(Simponi) Annual Revenue by Geographic Region
4.2 World Historic Golimumab(Simponi) Market Size by Country/Region (2017-2022)
4.2.1 Global Golimumab(Simponi) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Golimumab(Simponi) Annual Revenue by Country/Region
4.3 Americas Golimumab(Simponi) Sales Growth
4.4 APAC Golimumab(Simponi) Sales Growth
4.5 Europe Golimumab(Simponi) Sales Growth
4.6 Middle East & Africa Golimumab(Simponi) Sales Growth
5 AMERICAS
5.1 Americas Golimumab(Simponi) Sales by Country
5.1.1 Americas Golimumab(Simponi) Sales by Country (2017-2022)
5.1.2 Americas Golimumab(Simponi) Revenue by Country (2017-2022)
5.2 Americas Golimumab(Simponi) Sales by Specification
5.3 Americas Golimumab(Simponi) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Golimumab(Simponi) Sales by Region
6.1.1 APAC Golimumab(Simponi) Sales by Region (2017-2022)
6.1.2 APAC Golimumab(Simponi) Revenue by Region (2017-2022)
6.2 APAC Golimumab(Simponi) Sales by Specification
6.3 APAC Golimumab(Simponi) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Golimumab(Simponi) by Country
7.1.1 Europe Golimumab(Simponi) Sales by Country (2017-2022)
7.1.2 Europe Golimumab(Simponi) Revenue by Country (2017-2022)
7.2 Europe Golimumab(Simponi) Sales by Specification
7.3 Europe Golimumab(Simponi) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Golimumab(Simponi) by Country
8.1.1 Middle East & Africa Golimumab(Simponi) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Golimumab(Simponi) Revenue by Country (2017-2022)
8.2 Middle East & Africa Golimumab(Simponi) Sales by Specification
8.3 Middle East & Africa Golimumab(Simponi) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Golimumab(Simponi)
10.3 Manufacturing Process Analysis of Golimumab(Simponi)
10.4 Industry Chain Structure of Golimumab(Simponi)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Golimumab(Simponi) Distributors
11.3 Golimumab(Simponi) Customer
12 WORLD FORECAST REVIEW FOR GOLIMUMAB(SIMPONI) BY GEOGRAPHIC REGION
12.1 Global Golimumab(Simponi) Market Size Forecast by Region
12.1.1 Global Golimumab(Simponi) Forecast by Region (2023-2028)
12.1.2 Global Golimumab(Simponi) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Golimumab(Simponi) Forecast by Specification
12.7 Global Golimumab(Simponi) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Chemieliva Pharma
13.1.1 Chemieliva Pharma Company Information
13.1.2 Chemieliva Pharma Golimumab(Simponi) Product Offered
13.1.3 Chemieliva Pharma Golimumab(Simponi) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Chemieliva Pharma Main Business Overview
13.1.5 Chemieliva Pharma Latest Developments
13.2 JNJ
13.2.1 JNJ Company Information
13.2.2 JNJ Golimumab(Simponi) Product Offered
13.2.3 JNJ Golimumab(Simponi) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 JNJ Main Business Overview
13.2.5 JNJ Latest Developments
13.3 DSK Biopharma
13.3.1 DSK Biopharma Company Information
13.3.2 DSK Biopharma Golimumab(Simponi) Product Offered
13.3.3 DSK Biopharma Golimumab(Simponi) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 DSK Biopharma Main Business Overview
13.3.5 DSK Biopharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Golimumab(Simponi) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Golimumab(Simponi) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 100Mg/Ml
Table 4. Major Players of 50Mg/Ml
Table 5. Major Players of 10Mg/Ml
Table 6. Global Golimumab(Simponi) Sales by Specification (2017-2022) & (Box)
Table 7. Global Golimumab(Simponi) Sales Market Share by Specification (2017-2022)
Table 8. Global Golimumab(Simponi) Revenue by Specification (2017-2022) & ($ million)
Table 9. Global Golimumab(Simponi) Revenue Market Share by Specification (2017-2022)
Table 10. Global Golimumab(Simponi) Sale Price by Specification (2017-2022) & (US$/Box)
Table 11. Global Golimumab(Simponi) Sales by Application (2017-2022) & (Box)
Table 12. Global Golimumab(Simponi) Sales Market Share by Application (2017-2022)
Table 13. Global Golimumab(Simponi) Revenue by Application (2017-2022)
Table 14. Global Golimumab(Simponi) Revenue Market Share by Application (2017-2022)
Table 15. Global Golimumab(Simponi) Sale Price by Application (2017-2022) & (US$/Box)
Table 16. Global Golimumab(Simponi) Sales by Company (2020-2022) & (Box)
Table 17. Global Golimumab(Simponi) Sales Market Share by Company (2020-2022)
Table 18. Global Golimumab(Simponi) Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Golimumab(Simponi) Revenue Market Share by Company (2020-2022)
Table 20. Global Golimumab(Simponi) Sale Price by Company (2020-2022) & (US$/Box)
Table 21. Key Manufacturers Golimumab(Simponi) Producing Area Distribution and Sales Area
Table 22. Players Golimumab(Simponi) Products Offered
Table 23. Golimumab(Simponi) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Golimumab(Simponi) Sales by Geographic Region (2017-2022) & (Box)
Table 27. Global Golimumab(Simponi) Sales Market Share Geographic Region (2017-2022)
Table 28. Global Golimumab(Simponi) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Golimumab(Simponi) Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Golimumab(Simponi) Sales by Country/Region (2017-2022) & (Box)
Table 31. Global Golimumab(Simponi) Sales Market Share by Country/Region (2017-2022)
Table 32. Global Golimumab(Simponi) Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Golimumab(Simponi) Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Golimumab(Simponi) Sales by Country (2017-2022) & (Box)
Table 35. Americas Golimumab(Simponi) Sales Market Share by Country (2017-2022)
Table 36. Americas Golimumab(Simponi) Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Golimumab(Simponi) Revenue Market Share by Country (2017-2022)
Table 38. Americas Golimumab(Simponi) Sales by Type (2017-2022) & (Box)
Table 39. Americas Golimumab(Simponi) Sales Market Share by Specification (2017-2022)
Table 40. Americas Golimumab(Simponi) Sales by Application (2017-2022) & (Box)
Table 41. Americas Golimumab(Simponi) Sales Market Share by Application (2017-2022)
Table 42. APAC Golimumab(Simponi) Sales by Region (2017-2022) & (Box)
Table 43. APAC Golimumab(Simponi) Sales Market Share by Region (2017-2022)
Table 44. APAC Golimumab(Simponi) Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Golimumab(Simponi) Revenue Market Share by Region (2017-2022)
Table 46. APAC Golimumab(Simponi) Sales by Specification (2017-2022) & (Box)
Table 47. APAC Golimumab(Simponi) Sales Market Share by Specification (2017-2022)
Table 48. APAC Golimumab(Simponi) Sales by Application (2017-2022) & (Box)
Table 49. APAC Golimumab(Simponi) Sales Market Share by Application (2017-2022)
Table 50. Europe Golimumab(Simponi) Sales by Country (2017-2022) & (Box)
Table 51. Europe Golimumab(Simponi) Sales Market Share by Country (2017-2022)
Table 52. Europe Golimumab(Simponi) Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Golimumab(Simponi) Revenue Market Share by Country (2017-2022)
Table 54. Europe Golimumab(Simponi) Sales by Type (2017-2022) & (Box)
Table 55. Europe Golimumab(Simponi) Sales Market Share by Specification (2017-2022)
Table 56. Europe Golimumab(Simponi) Sales by Application (2017-2022) & (Box)
Table 57. Europe Golimumab(Simponi) Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Golimumab(Simponi) Sales by Country (2017-2022) & (Box)
Table 59. Middle East & Africa Golimumab(Simponi) Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Golimumab(Simponi) Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Golimumab(Simponi) Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Golimumab(Simponi) Sales by Specification (2017-2022) & (Box)
Table 63. Middle East & Africa Golimumab(Simponi) Sales Market Share by Specification (2017-2022)
Table 64. Middle East & Africa Golimumab(Simponi) Sales by Application (2017-2022) & (Box)
Table 65. Middle East & Africa Golimumab(Simponi) Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Golimumab(Simponi)
Table 67. Key Market Challenges & Risks of Golimumab(Simponi)
Table 68. Key Industry Trends of Golimumab(Simponi)
Table 69. Golimumab(Simponi) Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Golimumab(Simponi) Distributors List
Table 72. Golimumab(Simponi) Customer List
Table 73. Global Golimumab(Simponi) Sales Forecast by Region (2023-2028) & (Box)
Table 74. Global Golimumab(Simponi) Sales Market Forecast by Region
Table 75. Global Golimumab(Simponi) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Golimumab(Simponi) Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Golimumab(Simponi) Sales Forecast by Country (2023-2028) & (Box)
Table 78. Americas Golimumab(Simponi) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Golimumab(Simponi) Sales Forecast by Region (2023-2028) & (Box)
Table 80. APAC Golimumab(Simponi) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Golimumab(Simponi) Sales Forecast by Country (2023-2028) & (Box)
Table 82. Europe Golimumab(Simponi) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Golimumab(Simponi) Sales Forecast by Country (2023-2028) & (Box)
Table 84. Middle East & Africa Golimumab(Simponi) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Golimumab(Simponi) Sales Forecast by Specification (2023-2028) & (Box)
Table 86. Global Golimumab(Simponi) Sales Market Share Forecast by Specification (2023-2028)
Table 87. Global Golimumab(Simponi) Revenue Forecast by Specification (2023-2028) & ($ Millions)
Table 88. Global Golimumab(Simponi) Revenue Market Share Forecast by Specification (2023-2028)
Table 89. Global Golimumab(Simponi) Sales Forecast by Application (2023-2028) & (Box)
Table 90. Global Golimumab(Simponi) Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Golimumab(Simponi) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Golimumab(Simponi) Revenue Market Share Forecast by Application (2023-2028)
Table 93. Chemieliva Pharma Basic Information, Golimumab(Simponi) Manufacturing Base, Sales Area and Its Competitors
Table 94. Chemieliva Pharma Golimumab(Simponi) Product Offered
Table 95. Chemieliva Pharma Golimumab(Simponi) Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 96. Chemieliva Pharma Main Business
Table 97. Chemieliva Pharma Latest Developments
Table 98. JNJ Basic Information, Golimumab(Simponi) Manufacturing Base, Sales Area and Its Competitors
Table 99. JNJ Golimumab(Simponi) Product Offered
Table 100. JNJ Golimumab(Simponi) Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 101. JNJ Main Business
Table 102. JNJ Latest Developments
Table 103. DSK Biopharma Basic Information, Golimumab(Simponi) Manufacturing Base, Sales Area and Its Competitors
Table 104. DSK Biopharma Golimumab(Simponi) Product Offered
Table 105. DSK Biopharma Golimumab(Simponi) Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 106. DSK Biopharma Main Business
Table 107. DSK Biopharma Latest Developments
Table 1. Golimumab(Simponi) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Golimumab(Simponi) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 100Mg/Ml
Table 4. Major Players of 50Mg/Ml
Table 5. Major Players of 10Mg/Ml
Table 6. Global Golimumab(Simponi) Sales by Specification (2017-2022) & (Box)
Table 7. Global Golimumab(Simponi) Sales Market Share by Specification (2017-2022)
Table 8. Global Golimumab(Simponi) Revenue by Specification (2017-2022) & ($ million)
Table 9. Global Golimumab(Simponi) Revenue Market Share by Specification (2017-2022)
Table 10. Global Golimumab(Simponi) Sale Price by Specification (2017-2022) & (US$/Box)
Table 11. Global Golimumab(Simponi) Sales by Application (2017-2022) & (Box)
Table 12. Global Golimumab(Simponi) Sales Market Share by Application (2017-2022)
Table 13. Global Golimumab(Simponi) Revenue by Application (2017-2022)
Table 14. Global Golimumab(Simponi) Revenue Market Share by Application (2017-2022)
Table 15. Global Golimumab(Simponi) Sale Price by Application (2017-2022) & (US$/Box)
Table 16. Global Golimumab(Simponi) Sales by Company (2020-2022) & (Box)
Table 17. Global Golimumab(Simponi) Sales Market Share by Company (2020-2022)
Table 18. Global Golimumab(Simponi) Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Golimumab(Simponi) Revenue Market Share by Company (2020-2022)
Table 20. Global Golimumab(Simponi) Sale Price by Company (2020-2022) & (US$/Box)
Table 21. Key Manufacturers Golimumab(Simponi) Producing Area Distribution and Sales Area
Table 22. Players Golimumab(Simponi) Products Offered
Table 23. Golimumab(Simponi) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Golimumab(Simponi) Sales by Geographic Region (2017-2022) & (Box)
Table 27. Global Golimumab(Simponi) Sales Market Share Geographic Region (2017-2022)
Table 28. Global Golimumab(Simponi) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Golimumab(Simponi) Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Golimumab(Simponi) Sales by Country/Region (2017-2022) & (Box)
Table 31. Global Golimumab(Simponi) Sales Market Share by Country/Region (2017-2022)
Table 32. Global Golimumab(Simponi) Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Golimumab(Simponi) Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Golimumab(Simponi) Sales by Country (2017-2022) & (Box)
Table 35. Americas Golimumab(Simponi) Sales Market Share by Country (2017-2022)
Table 36. Americas Golimumab(Simponi) Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Golimumab(Simponi) Revenue Market Share by Country (2017-2022)
Table 38. Americas Golimumab(Simponi) Sales by Type (2017-2022) & (Box)
Table 39. Americas Golimumab(Simponi) Sales Market Share by Specification (2017-2022)
Table 40. Americas Golimumab(Simponi) Sales by Application (2017-2022) & (Box)
Table 41. Americas Golimumab(Simponi) Sales Market Share by Application (2017-2022)
Table 42. APAC Golimumab(Simponi) Sales by Region (2017-2022) & (Box)
Table 43. APAC Golimumab(Simponi) Sales Market Share by Region (2017-2022)
Table 44. APAC Golimumab(Simponi) Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Golimumab(Simponi) Revenue Market Share by Region (2017-2022)
Table 46. APAC Golimumab(Simponi) Sales by Specification (2017-2022) & (Box)
Table 47. APAC Golimumab(Simponi) Sales Market Share by Specification (2017-2022)
Table 48. APAC Golimumab(Simponi) Sales by Application (2017-2022) & (Box)
Table 49. APAC Golimumab(Simponi) Sales Market Share by Application (2017-2022)
Table 50. Europe Golimumab(Simponi) Sales by Country (2017-2022) & (Box)
Table 51. Europe Golimumab(Simponi) Sales Market Share by Country (2017-2022)
Table 52. Europe Golimumab(Simponi) Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Golimumab(Simponi) Revenue Market Share by Country (2017-2022)
Table 54. Europe Golimumab(Simponi) Sales by Type (2017-2022) & (Box)
Table 55. Europe Golimumab(Simponi) Sales Market Share by Specification (2017-2022)
Table 56. Europe Golimumab(Simponi) Sales by Application (2017-2022) & (Box)
Table 57. Europe Golimumab(Simponi) Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Golimumab(Simponi) Sales by Country (2017-2022) & (Box)
Table 59. Middle East & Africa Golimumab(Simponi) Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Golimumab(Simponi) Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Golimumab(Simponi) Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Golimumab(Simponi) Sales by Specification (2017-2022) & (Box)
Table 63. Middle East & Africa Golimumab(Simponi) Sales Market Share by Specification (2017-2022)
Table 64. Middle East & Africa Golimumab(Simponi) Sales by Application (2017-2022) & (Box)
Table 65. Middle East & Africa Golimumab(Simponi) Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Golimumab(Simponi)
Table 67. Key Market Challenges & Risks of Golimumab(Simponi)
Table 68. Key Industry Trends of Golimumab(Simponi)
Table 69. Golimumab(Simponi) Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Golimumab(Simponi) Distributors List
Table 72. Golimumab(Simponi) Customer List
Table 73. Global Golimumab(Simponi) Sales Forecast by Region (2023-2028) & (Box)
Table 74. Global Golimumab(Simponi) Sales Market Forecast by Region
Table 75. Global Golimumab(Simponi) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Golimumab(Simponi) Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Golimumab(Simponi) Sales Forecast by Country (2023-2028) & (Box)
Table 78. Americas Golimumab(Simponi) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Golimumab(Simponi) Sales Forecast by Region (2023-2028) & (Box)
Table 80. APAC Golimumab(Simponi) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Golimumab(Simponi) Sales Forecast by Country (2023-2028) & (Box)
Table 82. Europe Golimumab(Simponi) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Golimumab(Simponi) Sales Forecast by Country (2023-2028) & (Box)
Table 84. Middle East & Africa Golimumab(Simponi) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Golimumab(Simponi) Sales Forecast by Specification (2023-2028) & (Box)
Table 86. Global Golimumab(Simponi) Sales Market Share Forecast by Specification (2023-2028)
Table 87. Global Golimumab(Simponi) Revenue Forecast by Specification (2023-2028) & ($ Millions)
Table 88. Global Golimumab(Simponi) Revenue Market Share Forecast by Specification (2023-2028)
Table 89. Global Golimumab(Simponi) Sales Forecast by Application (2023-2028) & (Box)
Table 90. Global Golimumab(Simponi) Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Golimumab(Simponi) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Golimumab(Simponi) Revenue Market Share Forecast by Application (2023-2028)
Table 93. Chemieliva Pharma Basic Information, Golimumab(Simponi) Manufacturing Base, Sales Area and Its Competitors
Table 94. Chemieliva Pharma Golimumab(Simponi) Product Offered
Table 95. Chemieliva Pharma Golimumab(Simponi) Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 96. Chemieliva Pharma Main Business
Table 97. Chemieliva Pharma Latest Developments
Table 98. JNJ Basic Information, Golimumab(Simponi) Manufacturing Base, Sales Area and Its Competitors
Table 99. JNJ Golimumab(Simponi) Product Offered
Table 100. JNJ Golimumab(Simponi) Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 101. JNJ Main Business
Table 102. JNJ Latest Developments
Table 103. DSK Biopharma Basic Information, Golimumab(Simponi) Manufacturing Base, Sales Area and Its Competitors
Table 104. DSK Biopharma Golimumab(Simponi) Product Offered
Table 105. DSK Biopharma Golimumab(Simponi) Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 106. DSK Biopharma Main Business
Table 107. DSK Biopharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Golimumab(Simponi)
Figure 2. Golimumab(Simponi) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Golimumab(Simponi) Sales Growth Rate 2017-2028 (Box)
Figure 7. Global Golimumab(Simponi) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Golimumab(Simponi) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 100Mg/Ml
Figure 10. Product Picture of 50Mg/Ml
Figure 11. Product Picture of 10Mg/Ml
Figure 12. Global Golimumab(Simponi) Sales Market Share by Specification in 2021
Figure 13. Global Golimumab(Simponi) Revenue Market Share by Specification (2017-2022)
Figure 14. Golimumab(Simponi) Consumed in Hospital
Figure 15. Global Golimumab(Simponi) Market: Hospital (2017-2022) & (Box)
Figure 16. Golimumab(Simponi) Consumed in Clinic
Figure 17. Global Golimumab(Simponi) Market: Clinic (2017-2022) & (Box)
Figure 18. Golimumab(Simponi) Consumed in Other
Figure 19. Global Golimumab(Simponi) Market: Other (2017-2022) & (Box)
Figure 20. Global Golimumab(Simponi) Sales Market Share by Application (2017-2022)
Figure 21. Global Golimumab(Simponi) Revenue Market Share by Application in 2021
Figure 22. Golimumab(Simponi) Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Golimumab(Simponi) Revenue Market Share by Company in 2021
Figure 24. Global Golimumab(Simponi) Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Golimumab(Simponi) Revenue Market Share by Geographic Region in 2021
Figure 26. Global Golimumab(Simponi) Sales Market Share by Region (2017-2022)
Figure 27. Global Golimumab(Simponi) Revenue Market Share by Country/Region in 2021
Figure 28. Americas Golimumab(Simponi) Sales 2017-2022 (Box)
Figure 29. Americas Golimumab(Simponi) Revenue 2017-2022 ($ Millions)
Figure 30. APAC Golimumab(Simponi) Sales 2017-2022 (Box)
Figure 31. APAC Golimumab(Simponi) Revenue 2017-2022 ($ Millions)
Figure 32. Europe Golimumab(Simponi) Sales 2017-2022 (Box)
Figure 33. Europe Golimumab(Simponi) Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Golimumab(Simponi) Sales 2017-2022 (Box)
Figure 35. Middle East & Africa Golimumab(Simponi) Revenue 2017-2022 ($ Millions)
Figure 36. Americas Golimumab(Simponi) Sales Market Share by Country in 2021
Figure 37. Americas Golimumab(Simponi) Revenue Market Share by Country in 2021
Figure 38. United States Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Golimumab(Simponi) Sales Market Share by Region in 2021
Figure 43. APAC Golimumab(Simponi) Revenue Market Share by Regions in 2021
Figure 44. China Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Golimumab(Simponi) Sales Market Share by Country in 2021
Figure 51. Europe Golimumab(Simponi) Revenue Market Share by Country in 2021
Figure 52. Germany Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Golimumab(Simponi) Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Golimumab(Simponi) Revenue Market Share by Country in 2021
Figure 59. Egypt Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Golimumab(Simponi) in 2021
Figure 65. Manufacturing Process Analysis of Golimumab(Simponi)
Figure 66. Industry Chain Structure of Golimumab(Simponi)
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Figure 1. Picture of Golimumab(Simponi)
Figure 2. Golimumab(Simponi) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Golimumab(Simponi) Sales Growth Rate 2017-2028 (Box)
Figure 7. Global Golimumab(Simponi) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Golimumab(Simponi) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 100Mg/Ml
Figure 10. Product Picture of 50Mg/Ml
Figure 11. Product Picture of 10Mg/Ml
Figure 12. Global Golimumab(Simponi) Sales Market Share by Specification in 2021
Figure 13. Global Golimumab(Simponi) Revenue Market Share by Specification (2017-2022)
Figure 14. Golimumab(Simponi) Consumed in Hospital
Figure 15. Global Golimumab(Simponi) Market: Hospital (2017-2022) & (Box)
Figure 16. Golimumab(Simponi) Consumed in Clinic
Figure 17. Global Golimumab(Simponi) Market: Clinic (2017-2022) & (Box)
Figure 18. Golimumab(Simponi) Consumed in Other
Figure 19. Global Golimumab(Simponi) Market: Other (2017-2022) & (Box)
Figure 20. Global Golimumab(Simponi) Sales Market Share by Application (2017-2022)
Figure 21. Global Golimumab(Simponi) Revenue Market Share by Application in 2021
Figure 22. Golimumab(Simponi) Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Golimumab(Simponi) Revenue Market Share by Company in 2021
Figure 24. Global Golimumab(Simponi) Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Golimumab(Simponi) Revenue Market Share by Geographic Region in 2021
Figure 26. Global Golimumab(Simponi) Sales Market Share by Region (2017-2022)
Figure 27. Global Golimumab(Simponi) Revenue Market Share by Country/Region in 2021
Figure 28. Americas Golimumab(Simponi) Sales 2017-2022 (Box)
Figure 29. Americas Golimumab(Simponi) Revenue 2017-2022 ($ Millions)
Figure 30. APAC Golimumab(Simponi) Sales 2017-2022 (Box)
Figure 31. APAC Golimumab(Simponi) Revenue 2017-2022 ($ Millions)
Figure 32. Europe Golimumab(Simponi) Sales 2017-2022 (Box)
Figure 33. Europe Golimumab(Simponi) Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Golimumab(Simponi) Sales 2017-2022 (Box)
Figure 35. Middle East & Africa Golimumab(Simponi) Revenue 2017-2022 ($ Millions)
Figure 36. Americas Golimumab(Simponi) Sales Market Share by Country in 2021
Figure 37. Americas Golimumab(Simponi) Revenue Market Share by Country in 2021
Figure 38. United States Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Golimumab(Simponi) Sales Market Share by Region in 2021
Figure 43. APAC Golimumab(Simponi) Revenue Market Share by Regions in 2021
Figure 44. China Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Golimumab(Simponi) Sales Market Share by Country in 2021
Figure 51. Europe Golimumab(Simponi) Revenue Market Share by Country in 2021
Figure 52. Germany Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Golimumab(Simponi) Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Golimumab(Simponi) Revenue Market Share by Country in 2021
Figure 59. Egypt Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Golimumab(Simponi) Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Golimumab(Simponi) in 2021
Figure 65. Manufacturing Process Analysis of Golimumab(Simponi)
Figure 66. Industry Chain Structure of Golimumab(Simponi)
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
